In the precise diagnosis of clinical testing and the transformation of achievements in biopharmaceutical research and development,AWARENESS ELISA readerWith its stable photoelectric detection performance, it has become a core device for analyzing biological signals. Relying on multiple detection technologies such as absorbance and fluorescence, it can not only efficiently complete basic tests such as ELISA and protein quantification, but also adapt to complex projects such as tumor marker screening and cytokine analysis, providing comprehensive support from qualitative judgment to quantitative analysis for different scenarios, and becoming the "data generator" of the laboratory.

In the field of clinical laboratory testing, ELISA related detection is the core application scenario of AWARENESS enzyme-linked immunosorbent assay, especially playing a key role in infectious disease screening and chronic disease monitoring. For viral hepatitis such as hepatitis B and hepatitis C, StatFax-2100 and other models can accurately detect hepatitis B B surface antigen (HBsAg) and hepatitis C antibody (anti HCV) in serum by indirect ELISA, and capture weak signals of early infection with absorbance accuracy of ± 0.005Abs. In the diagnosis of autoimmune diseases, this device supports the detection of items such as anti nuclear antibodies (ANA) and rheumatoid factor (RF), and eliminates interference factors such as hemolysis and hyperlipidemia through dual wavelength detection mode, providing reliable diagnostic basis for diseases such as systemic lupus erythematosus and rheumatoid arthritis. In addition, in sex hormone testing, it can be used in conjunction with competitive ELISA to measure estradiol and testosterone levels, helping to accurately diagnose and treat endocrine disorders.

Protein quantitative detection is a fundamental step in the development of biomedicine, and the AWARENESS enzyme-linked immunosorbent assay (ELISA) reader can be adapted to various classic methods to meet different needs. For complex samples such as cell lysate and serum, it supports BCA protein quantification and achieves accurate quantification in the concentration range of 10-1200 μ g/mL by detecting the absorbance of the purple complex generated by Cu ² ⁺ reduction reaction in alkaline environment. It is compatible with commonly used detergents and will not affect the stability of the results. The UV absorption method (280nm) is suitable for high-purity protein samples, and can be quickly quantified through the characteristic absorption peaks of aromatic amino acids without the need for reagents, greatly improving research and development efficiency.

The highly specific detection capability of the AWARENESS enzyme-linked immunosorbent assay (ELISA) is fully utilized in tumor diagnosis and treatment monitoring. It can accurately detect conventional tumor markers such as alpha fetoprotein (AFP) and carcinoembryonic antigen (CEA) in serum through sandwich ELISA method, with a detection limit as low as ng level, meeting the needs of early screening. For patients with breast cancer, the device can quantitatively analyze the expression level of HER-2 protein, providing a basis for targeted drug use; In colorectal cancer monitoring, dynamic detection of carbohydrate antigen CA-199 can effectively evaluate treatment efficacy and recurrence risk. These tests rely on the multi-point calibration function of the equipment to ensure the consistency of testing data from different batches.

In the field of biopharmaceutical research and development, the AWARENESS enzyme-linked immunosorbent assay (ELISA) also supports characteristic projects such as cell function analysis and drug screening. In cell proliferation and toxicity testing, the activity of mitochondrial dehydrogenase in live cells is detected by MTT assay, and the inhibitory or promoting effect of drugs on cells is quantified by changes in absorbance. In the study of inflammatory mechanisms, ELISA kits can be used to measure the concentrations of cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF - α), which can assist in the evaluation of anti-inflammatory drug activity. Some models also support fluorescence detection mode, which enables trace analysis of low abundance proteins through fluorescence probe labeling, providing technical support for biomarker discovery.

From batch screening in clinical laboratories to research and development workbenches in pharmaceutical companies, the AWARENESS enzyme-linked immunosorbent assay (ELISA) reader is adaptable to different scene requirements with multiple detection capabilities. It ensures diagnostic accuracy in ELISA detection, builds a solid research and development foundation in protein quantification, and assists in early screening and treatment in tumor marker detection. With technological upgrades, this device is simplifying operational processes, improving data transmission efficiency, and further lowering usage barriers, becoming an important technological bridge connecting basic research and clinical applications, continuously empowering the development of the life sciences field.